{"id":410918,"date":"2020-10-15T17:10:01","date_gmt":"2020-10-15T14:10:01","guid":{"rendered":"https:\/\/analyse.optim.biz\/?p=410918"},"modified":"2020-10-15T17:10:01","modified_gmt":"2020-10-15T14:10:01","slug":"cand-va-putea-si-romania-sa-produca-remdesivir-necesar-in-tratamentul-covid-19-ce-spune-ministrul-sanatatii","status":"publish","type":"post","link":"https:\/\/analyse.optim.biz\/?p=410918","title":{"rendered":"C\u00e2nd va putea \u0219i Rom\u00e2nia s\u0103 produc\u0103 Remdesivir, necesar \u00een tratamentul COVID-19? Ce spune ministrul S\u0103n\u0103t\u0103\u021bii"},"content":{"rendered":"<\/p>\n<h2>\n\t\t\t\t\t\t\t\t\t\t\t Nelu T\u0103taru spune c\u0103 acum este imposibil ca Remdesivir s\u0103 fie produs \u00een Rom\u00e2nia. Medicamentul antiviral utilizat pentru bolnavii cu forme medii \u0219i severe de COVID-19 va putea fi produs abia peste cel pu\u021bin doi ani \u0219i \u00een \u021bara noastr\u0103, a spus, joi, ministrul S\u0103n\u0103t\u0103\u021bii, la Timi\u0219oara.<br \/>\n\t\t\t\t\t\t\t\t\t\t<\/h2>\n<div class=\"realitatea-article-content-box\">\n<p>\u00a0<\/p>\n<p>\u201eRom\u00e2nia nu va putea produce Remdesivir nici \u00een acest an \u0219i nici anul viitor\u201d, a declarat ministrul S\u0103n\u0103t\u0103\u021bii, potrivit <a href=\"https:\/\/www.tion.ro\/sanatate\/ministrul-sanatatii-nelu-tataru-la-timisoara-1355408\/\" target=\"_blank\" rel=\"noopener\">tion.ro<\/a>.<\/p>\n<div class=\"d-flex justify-content-center w-100 flex-row mt-5 mb-5 advert-970-250-m-300-250\">\n                                <!-- \/32628511\/Realitatea.netV2_articol\/300x250_ia_3 &amp; \/32628511\/Realitatea.netV2_articol_mobile\/300x600\/\/300x250_1 --><\/p>\n<div id=\"div-gpt-ad-1625071071304-0\"><\/div>\n<div id=\"div-gpt-ad-1625070521521-0\"><\/div>\n<\/p><\/div>\n<p>Ministrul S\u0103n\u0103t\u0103\u021bii a declarat joi, la Timi\u0219oara, c\u0103 a discutat \u00eenc\u0103 din var\u0103 despre posibilitatea ca Remdesivir s\u0103 fie produs \u0219i \u00een Rom\u00e2nia, \u00eens\u0103 pentru aceasta este nevoie de ob\u021binerea patentului \u0219i de o linie tehnologic\u0103.<\/p>\n<div id=\"in-article-teads\"><\/div>\n<p>\u201eNoi avem aceste discu\u0163ii \u00eenc\u0103 din var\u0103. Avem fabrica Antibiotice, la care am avut aceast\u0103 discu\u0163ie, n-are linie tehnologic\u0103 \u015fi trebuie ob\u0163inut acel patent. Dar linia tehnologic\u0103 \u00eenc\u0103 nu o avem. Ar fi o perioad\u0103 destul de lung\u0103 s\u0103 putem produce acest Remdesivir (&#8230;) Din ce am discutat cu produc\u0103torii de medicamente, anul acesta \u015fi anul viitor nu vom putea produce Remdesivir. Trebuie o linie tehnologic\u0103 plus o linie special\u0103 pentru Remdesivir, plus patentul&#8221;, a afirmat ministrul Nelu T\u0103taru.<\/p>\n<div class=\"d-flex justify-content-center w-100 flex-row mt-5 mb-5 advert-970-250-m-300-250\">\n                                <!-- \/32628511\/Realitatea.netV2_articol\/300x250_ia_4 &amp; \/32628511\/Realitatea.netV2_articol_mobile\/300x600\/\/300x250_2 --><\/p>\n<div id=\"div-gpt-ad-1625071089075-0\"><\/div>\n<div id=\"div-gpt-ad-1625070536172-0\"><\/div>\n<\/p><\/div>\n<p>\u201eTotul \u0163ine de produc\u0103tor \u015fi produc\u0103torii no\u015ftri au anumite linii tehnologice \u015fi anumit\u0103 produc\u0163ie pe anumite produse\u201d, a mai explicat Nelu T\u0103taru.<\/p>\n<p>Ministrul Nelu T\u0103taru a fost \u00eentrebat, joi, la Timi\u015foara, de jurnali\u0219ti de ce statul rom\u00e2n nu a f\u0103cut demersuri, la fel ca \u015fi cel ungar, s\u0103 ob\u0163in\u0103 licen\u0163\u0103 pentru produc\u0163ia de Remdesivir. <a href=\"http:\/\/www.realitatea.net\/stiri\/actual\/ungaria-a-inceput-dezvoltarea-propriei-linii-de-fabricare-a-remdesivir-a-fost-testat-pe-250-de-pacienti_5f81a29221aa59704a6d2e19\" target=\"_blank\" rel=\"noopener\">Ungaria produce deja Remdesivir<\/a>. La sf\u00e2r\u0219itul s\u0103pt\u0103m\u00e2nii trecute, Ungaria a \u00eenceput dezvoltarea propriei linii de fabricare a Remdesivir. Medicamentul este produs de fabrica ungar\u0103 Gedeon Richter, care a produs deja primele doze pentru 3.000 de pacien\u0163i.<\/p>\n<\/p>\n<p>T\u0103taru a mai spus, miercuri, c\u0103 statul rom\u00e2n sprijin\u0103 aceste firme de medicamente s\u0103 ob\u0163in\u0103 licen\u0163\u0103, iar miercuri a avut loc o discu\u0163ie la nivelul Guvernului, coordonat\u0103 de vicepremierul Raluca Turcan, cu to\u0163i produc\u0103torii de medicamente rom\u00e2ni \u015fi cu capital mixt.<\/p>\n<div class=\"d-flex justify-content-center w-100 flex-row mt-5 mb-5 advert-970-250-m-300-250\">\n                                <!-- \/32628511\/Realitatea.netV2_articol\/300x250_ia_5 &amp; \/32628511\/Realitatea.netV2_articol_mobile\/300x600\/\/300x250_3 --><\/p>\n<div id=\"div-gpt-ad-1625071108131-0\"><\/div>\n<div id=\"div-gpt-ad-1625070551720-0\"><\/div>\n<\/p><\/div>\n<p>\u201eAu solicitat \u015fi noi am pus la dispozi\u0163ie facilit\u0103\u0163i pentru a-\u015fi putea retehnologizara liniile \u015fi pentru a avea anumite beneficii fiscale \u00een condi\u0163iile fac acest\u201d, a mai spus T\u0103taru.<\/p>\n<p>\u00cen plus, multe spitale din Rom\u00e2nia au r\u0103mas f\u0103r\u0103 Remdesivir, iar ministrul T\u0103taru a declarat c\u0103 , dac\u0103 din iulie p\u00e2n\u0103 \u00een septembrie, Rom\u00e2nia a primit de la Comisia European\u0103 aproape 12.000 de doze, prin dona\u021bii, pentru octombrie, Ministerul S\u0103n\u0103t\u0103\u021bii are un contract subsecvent pentru alte 12.000 de doze, care vor fi repartizate tuturor spitalelor suport-COVID sau cele de faz\u0103 1, faz\u0103 2.<\/p>\n<p>Legat de producerea antiviralului \u00een Rom\u00e2nia, premierul Ludovic Orban a declarat c\u0103 \u201edecizia politic\u0103 exist\u0103 \u015fi \u00een privin\u0163a Remdesivir \u015fi \u00een privin\u0163a Favipiravir, problema este s\u0103 existe companii care s\u0103 aib\u0103 capacitatea s\u0103 introduc\u0103 \u00een fabrica\u0163ie \u015fi mai ales s\u0103 existe \u00eendeplinite condi\u0163iile legale pentru a putea produce \u015fi vinde pe pia\u0163\u0103 acest medicament\u201d.<\/p>\n<p>Remdesivir, care a fost administrat \u0219i pre\u0219edintelui SUA, Donald Trump,\u00a0este produs \u00een prezent \u015fi de compania Gedeon Richter din Ungaria, unde statul ungar este ac\u0163ionar cu un procent de peste 5%. Gedeon Richter are o fabric\u0103 \u015fi \u00een Rom\u00e2nia, la T\u00e2rgu Mure\u015f, potrivit <a href=\"https:\/\/www.zf.ro\/companii\/poate-vreun-producator-de-medicamente-din-romania-sa-fabrice-19652238\" target=\"_blank\" rel=\"noopener\">zf.ro<\/a>, care citeaz\u0103 Reuters. Guvernul ungar a \u00eentrebat produc\u0103torul de medicamente Richter dac\u0103 poate produce Remdesivir la nivel local, iar \u00een cinci luni acest lucru a fost posibil, procesul fiind finan\u0163at de guvern.<\/p>\n<\/div>\n<p>Source URL: https:\/\/www.realitatea.net\/stiri\/actual\/cand-va-putea-si-romania-sa-produca-remdesivir-necesar-in-tratamentul-covid19-ce-spune-ministrului-sanatatii_5f8858398c47ff475d306e83<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nelu T\u0103taru spune c\u0103 acum este imposibil ca Remdesivir s\u0103 fie produs \u00een Rom\u00e2nia. Medicamentul antiviral utilizat pentru bolnavii cu forme medii \u0219i severe de COVID-19 va putea fi produs abia peste cel pu\u021bin doi ani \u0219i \u00een \u021bara noastr\u0103, a spus, joi, ministrul S\u0103n\u0103t\u0103\u021bii, la Timi\u0219oara. \u00a0 \u201eRom\u00e2nia nu va putea produce Remdesivir nici [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":410919,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[15],"class_list":["post-410918","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-politics","tag-realitatea-net"],"_links":{"self":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts\/410918","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=410918"}],"version-history":[{"count":0,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts\/410918\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/media\/410919"}],"wp:attachment":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=410918"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=410918"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=410918"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}